A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Chronic Obstructive Pulmonary Disease
In brief
Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).
Key facts
- Study ID
- NCT06944925
- Run by
- Bambusa Therapeutics
- People needed
- 286
- Starts
- 2025-05-08
- Expected to finish
- 2027-07-31
- Last updated by the study team
- 2026-07-01
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Equity Medical Bowling Green — Bowling Green, Kentucky, United States (enrolling)
- LEPL The First University Clinic of Tbilisi State Medical University — Tbilisi, Georgia (enrolling)
- Ltd Aversi Clinic — Tbilisi, Georgia (enrolling)
- Momentum Clinical Research — Pukekohe, New Zealand (enrolling)
- Momentum Clinical Research — Wellington, New Zealand (enrolling)
- Equity Medical LLC — New York, New York, United States (enrolling)
- Linear Clinical Research — Perth, Western Australia, Australia (enrolling)
- Momentum Clinical Research — Brisbane, Australia (enrolling)
- Aleksandre Aladashvili Clinic LLC — Tbilisi, Georgia (enrolling)
- Geo Hospitals Tbilisi Multiprofile Medical Center — Tbilisi, Georgia (enrolling)
- Equity Medical - Owensboro — Owensboro, Kentucky, United States
- Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o. — Krakow, Poland
- Momentum Clinical Research Hamilton — Rotorua, Hamilton, New Zealand
- Uniwersyteckie Centrum Kliniczne Osrodka Badan Klinicznych Wczesnych Faz — Gdansk, Poland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.